The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power ...

We know that engaging with HCPs is incredibly valuable for medical education, with 48% of HCPs from a McKinsey Pharma ...

BioNTech’s BNT327 is being evaluated in multiple clinical trials, including phase 3 studies in first-line lung cancer ...

AstraZeneca (AZ) has announced that a wider range of chronic kidney disease (CKD) patients across England and Wales will be ...

NHS frameworks, such as Patient and Public Involvement, have demonstrated the value of integrating patient perspectives into ...

The phase 3 IMforte study randomised adults with extensive-stage SCLC to receive Roche’s PD-L1 inhibitor Tecentriq ...

Sanofi has announced that it will be expanding its immunology capabilities by acquiring US-based Blueprint Medicines ...

Lilly’s Omvoh is already recommended by NICE to treat certain cases of ulcerative colitis, another of the two main forms of ...

Pfizer has shared positive survival results from a late-stage study of its Braftovi (encorafenib) regimen in patients with ...

While sounding like an obvious statement, strategic planning is pivotal in shaping long-term success. However, given the lack ...

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on ...

The key to success lies in striking the right balance: leveraging AI’s capabilities while maintaining the human elements that ...